StonvexLoading…
StonvexStonvexStonvexCore line items from IRD's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $2.16M | $14.20M | $10.33M | $7.25M |
Operating Income | $-14.36M | $-38.60M | $-27.15M | $-18.84M |
Net Income | $-65.53M | $-49.59M | $-33.07M | $-7.42M |
EPS (Diluted) | $-0.75 | $-0.80 | $-0.59 | $-0.32 |
Total Assets | $66.79M | $50.24M | $36.12M | $38.66M |
Total Liabilities | $87.89M | $34.90M | $30.16M | $21.19M |
Cash & Equivalents | $59.96M | $45.09M | $30.82M | $32.43M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 71.40M | 69.89M | 64.54M | 59.91M |